RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
RevBio has raised $2.2M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
RevBio's investors include MassChallenge, National Institutes of Health, National Institute on Aging, MedTech Innovator, National Institute of Neurological Disorders and Stroke.
RevBio is headquartered in Lowell, United States.
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
RevBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RevBio — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/revbio. Accessed July 18, 2026.
VCBacked. (2025). RevBio — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/revbio
{{cite web |title=RevBio — Funding & Investors |url=https://www.vcbacked.co/company/revbio |website=VCBacked |access-date=July 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated